Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Human Genetics

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Chondrocalcinosis and the haemochromatosis-linked <i>HFE</i> C282Y homozygous variant in the UK Biobank.

EULAR rheumatology open·2026

Same author

Predictors of MRI-estimated brain iron deposition in dementia and Parkinson's disease-associated subcortical regions: Genetic and observational analysis in UK Biobank.

Journal of Alzheimer's disease : JAD·2025

Same author

A systematic analysis of the contribution of genetics to multimorbidity and comparisons with primary care data.

EBioMedicine·2025

Same author

Mitochondrial DNA copy number associated dementia risk by somatic mutations and frailty.

GeroScience·2024

Same author

Incidence of liver complications with hemochromatosis-associated HFE p.C282Y homozygosity: The role of central adiposity.

Hepatology (Baltimore, Md.)·2024

Same author

MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: Observational and genetic analysis in the UK Biobank cohort.

Neurobiology of disease·2024

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Genetic polymorphisms and human aging: association studies deliver.

¹Genetics of Ageing Group, Epidemiology and Public Health, Peninsula College of Medicine and Dentistry, Exeter, United Kingdom. david.melzer@pms.ac.uk

Rejuvenation Research

|March 18, 2008

Summary

Genetic variations influence how people age. A study found that changes in the p16/p15 gene region significantly impact physical functioning in older adults, highlighting its role in aging.

More Related Videos

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

Related Experiment Videos

Last Updated: Jul 6, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

Area of Science:

Genetics
Aging Biology
Gerontology

Background:

Aging is a complex process with significant individual variability.
Genetic factors play a substantial role in this heterogeneity.
The p16/p15 locus (INK4a/INK4b, CDKN2a/b) has emerged as a region of interest in aging research.

Purpose of the Study:

To investigate the association between genetic polymorphisms in the p16/p15 locus and physical functioning in older populations.
To explore the role of the p16/p15 region as a key site influencing aging processes.

Main Methods:

A candidate gene study was conducted across three distinct older populations.
Analysis focused on polymorphisms within the p16/p15 locus (CDKN2a/b).
Physical functioning levels were assessed in relation to identified genetic variations.

Main Results:

Polymorphisms in the p16/p15 locus were significantly associated with differences in physical functioning levels.
Genome-wide association studies (GWA) for type 2 diabetes and myocardial infarction also identified major variants in this locus.
These findings reinforce the p16/p15 region's importance as a critical aging site.

Conclusions:

The p16/p15 gene region is a key determinant of physical functioning and a significant factor in the aging process.
Genetic variations in this locus contribute to the heterogeneity of aging.
Discoveries in novel pathways from GWA studies offer potential targets for interventions to slow aging.